publication venue for
- Clinical cardiotoxicity of 5-fluorouracil. 1993
- Neurological Immune-Related Adverse Events After COVID-19 Vaccination: A Systematic Review.. 62. 2022
- Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.. 57. 2016
- Bridging the Academia/Industry Chasm: Proposed Solutions.. 56. 2016
- Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.. 56. 2016
- Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.. 54. 2014
- Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.. 53. 2013
- Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer.. 52. 2011
- Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.. 47. 2007
- Population pharmacokinetics of oxycodone in children 6 months to 7 years old.. 46. 2006
- Pharmacogenetic principles in the Hippocratic writings.. 45. 2005
- Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis.. 45. 2005
- Levofloxacin pharmacokinetics in children.. 45. 2005
- Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.. 44. 2004
- Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention.. 44. 2004
- Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.. 44. 2004
- The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients.. 43. 2003
- A limited sampling strategy for the estimation of 12-hour SangCya and neoral AUCs in renal transplant recipients.. 39. 1999
- The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.. 33. 1993
- The effects of nicardipine on sodium and calcium metabolism in hypertensive patients: a chronic study.. 30. 1990
- The effect of various postphlebotomy storage conditions on drug levels.. 28. 1988
- Increased erythrocyte calcium in alcoholism.. 22. 1982
- Imaging transgene expression for gene therapy. 1999
- Raloxifene, a new selective estrogen receptor modulator. 1999
- Developments in the therapeutic applications of bisphosphonates. 1999
- Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target. 1998
- Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. 1995
- New drugs in acute myelogenous leukemia: a review. 1992